![Ronald Crystal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Crystal
Fondateur chez
Xylocor Therapeutics, Inc.
Profil
Ronald G.
Crystal is the founder of GenVec, Inc. (1992), Xylocor Therapeutics, Inc. (2013), and Lexeo Therapeutics, Inc. (2017).
At Xylocor Therapeutics, Inc., he holds the title of Director.
Dr. Crystal is currently the Chairman of Genetic Medicine at Weill Cornell Medical College.
Crystal is also the founder of Annapurna Therapeutics SAS.
Postes actifs de Ronald Crystal
| Sociétés | Poste | Début |
|---|---|---|
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Fondateur | 01/01/2013 |
Anciens postes connus de Ronald Crystal
| Sociétés | Poste | Fin |
|---|---|---|
| GENVEC INC | Fondateur | - |
| LEXEO THERAPEUTICS, INC. | Fondateur | - |
Annapurna Therapeutics SAS
 Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annapurna Therapeutics SAS
Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
